The online version of this article (doi:10.1186/1471-2261-14-146) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interest.
AHSR: study design, data collection, statistical analysis and drafting of the manuscript. OCBW: study coordination. ASA: study design, data collection and drafting of the manuscript. LES: data collection and statistical analysis. PDP: study design and study coordination. All authors read and approved the final manuscript.
The choice of prosthesis for mitral valve replacement still remains controversial. This study assessed mortality, bleeding events and reoperation in patients who underwent mitral valve replacement surgery with biological or mechanical substitutes.
A total of 352 patients who underwent mitral valve replacement surgery between 1990 and 2008 with 5 to 23 years of follow-up were retrospectively evaluated in a cohort study.
The 5, 10, 15 and 20 year survival rates after surgery using a mechanical substitute were 87.7%, 74.2%, 69.3% and 69.3%, respectively, while after surgery with a biological substitute, they were 87.6%, 71.0%, 64.2% and 56.6%, respectively. There was no significant difference between the two groups (p = 0.38). In the multivariate analysis, the factors associated with death were age, bleeding events and renal failure. The probabilities of remaining free of reoperation at 5, 10, 15 and 20 years after surgery using a mechanical substitute were 94.4%, 92.7%, 92.7% and 92.7%; after surgery with a bioprosthesis, they were 95.9%, 86.4%, 81.2% and 76.5%, respectively (p = 0.073). There was a significantly higher incidence of reoperation for the bioprosthetic valve replacement group (p = 0.008). The probabilities of remaining free of bleeding events at 5, 10, 15 and 20 years after surgery using a mechanical substitute were 95.0%, 91.0%, 89.6% and 89.6%, respectively, while after surgery with a bioprosthesis, they were 96.9%, 94.0%, 94.0% and 94.0%, (p = 0.267).
The authors concluded that: 1) mortality during follow-up was statistically similar for both groups; 2) there was a greater tendency to reoperation in the bioprosthesis group; 3) the probability of remaining free from reoperation remained unchanged after 10 years’ follow-up for patients with mechanical substitute valves; 4) the probability of remaining fee from bleeding events remained unchanged after 10 years’ follow-up for patients given bioprostheses; 5) the baseline characteristics of patients were the greatest determinants of later mortality after surgery; 6) the type of prosthesis was not an independent predictive factor of any of the outcomes tested in the multivariate analysis.
Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O`Gara PT, O`Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll of Cardiol. 2006, 2006 (48): e1-e148. CrossRef
Instituto Brasileiro de Geografia e Estatística. 2013, http://www.ibge.gov.br/home/. Assessed at: June 9th
Ministério da Saúde. Departamento de Informática do SUS – DATASUS. Informações de Saúde. Assistência à Saúde. Internações hospitalares: Procedimentos hospitalares por gestor - a partir de 2008. 2013, http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sih/cnv/qgbr.def. Assessed at: sep 26 th
Hammermeister KE, Henderson WG, Burchfiel CM, Sethi GK, Souchek J, Oprian C, Cantor AB, Folland E, Khuri S, Rahimtoola S: Comparison of outcome after valve replacement with a bioprosthesis versus a mechanical prosthesis: initial 5 year results of a randomized trial. J Am Coll of Cardiol. 1987, 10: 719-732. 10.1016/S0735-1097(87)80263-2. CrossRef
Rahimtoola SH: Choice of prosthetic heart valve for adult patients. J Am Coll of Cardiol. 2003, 41: 893-904. 10.1016/S0735-1097(02)02965-0. CrossRef
Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S: A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans affairs cooperative study on valvular heart disease. N Engl J Med. 1993, 328: 1289-1296. 10.1056/NEJM199305063281801. CrossRefPubMed
Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH: Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll of Cardiol. 2000, 36: 1152-1158. 10.1016/S0735-1097(00)00834-2. CrossRef
Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61: 344-349. 10.1016/j.jclinepi.2007.11.008. CrossRefPubMed
Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW: Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg. 2008, 85: 1490-1495. 10.1016/j.athoracsur.2007.12.082. CrossRefPubMed
Nowicki ER, Birkmeyer NJ, Weintraub RW, Leavitt BJ, Sanders JH, Dacey LJ, Clough RA, Quinn RD, Charlesworth DC, Sisto DA, Uhlig PN, Olmstead EM, O`Connor GT for the Northern New England Cardiovascular Disease Study Group and the Center for Evaluative Clinical Sciences: Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg. 2004, 77: 1966-1977. 10.1016/j.athoracsur.2003.12.035. CrossRefPubMed
Jamieson WR, Von Lipinski O, Miyagishima RT, Burr LH, Janusz MT, Ling H, Fradet GJ, Chan F, Germann E: Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Surg. 2005, 129: 1301-1308. 10.1016/j.jtcvs.2004.09.042. CrossRefPubMed
- Comparison of clinical outcomes in patients undergoing mitral valve replacement with mechanical or biological substitutes: a 20 years cohort
Angela Henrique Silva Ribeiro
Orlando Carlos Belmonte Wender
Adriana Silveira de Almeida
Luciana Eltz Soares
Paulo Dornelles Picon
- BioMed Central
Neu im Fachgebiet Kardiologie
Mail Icon II